Home
About Us
Company Overview
Innovation and Leadership
Products
Discovery
Company Highlights
Company History
Our People
Senior Management
Our Reach
Awards and Recognition
Australian Industry Participation Purchasing Policy
Positions Vacant
Legal Disclaimer
Our Products
Aridol
Current clinical trials
Aridol Distributors
Bronchitol
Current clinical trials
Bronchitol Product Information
Bronchitol Distributors
Respiratory Diseases
Named Patient Program (Compassionate Use)
Scientific Publications
Patents
Investors
ASX Announcements
ASX 2012
ASX 2011
ASX 2010
ASX 2009
ASX 2008
ASX 2007
ASX 2006
ASX 2005
ASX 2004
ASX 2003
News
Quarterly Reports
Annual Reports
Investor Presentations
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
Share Price
Shareholder Services
Join Our Mailing List
Contact Us
Events Calendar
Financial Summary
Analyst Coverage
Shareholders
Corporate Directory
Corporate Governance
SEC Filings
Pharmaxis ADRs
News
Media Releases
Media 2012
Media 2011
Media 2010
Media 2009
Media 2008
Media 2007
Media 2006
Media 2005
Media 2004
Media 2003
Quarterly Reports
Quarterly Reports 2012
Quarterly Reports 2011
Quarterly Reports 2010
Quarterly Reports 2009
Quarterly Reports 2008
Quarterly Reports 2007
Quarterly Reports 2006
Quarterly Reports 2005
Quarterly Reports 2004
Media Contact
News Feeds
New Product Pipeline
Clinical Trials
Scientific Publications
Investigator-Initiated Studies
Respiratory diseases
Patents
Contact Us
Health Professionals
Patients
Investor 2010
Investor Presentation - Updated November 2010
CEO Presentation to 2010 AGM
Investor Presentation - Updated March 2010
Updated Investor Presentation - January 2010
Archived News
Pharmaxis
Home
Investor Presentations
Investor Presentation - Updated March 2010
02.03.2010 - Investor Presentation - Updated March 2010
View Presentation
Back to Latest News